Eight Roads Venture backed PlasmaGen Biosciences raises Rs 150 crore; valued at Rs 1,500 crore
Published on: Dec. 22, 2025, 2:01 p.m. | Source: The Economic Times
PlasmaGen Biosciences has secured Rs 150 crore in a funding round led by ViNS Bioproducts, valuing the company at over Rs 1,500 crore. This capital will fuel international expansion, product portfolio growth, and manufacturing enhancements. The funding follows the recent commissioning of India's first pure-play plasma biopharma facility, positioning PlasmaGen for significant growth.
